AMAli Moravej

Ali Moravej

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ali Moravej has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association of Interleukin-27 Gene Variants with Susceptibility to Brucellosis Among Iranian Population: A Case–Control Study

    by Mehdi Kalani, Erfane Fattah, Sadaf Asaei, Maral Choopanizadeh, Mahtab Kalani, Leila Saffar, Hojat Shahbazi, Ali Moravej, Zahra Montaseri

    Objectives: Brucellosis is recognized as one of the most widespread zoonotic diseases, caused by facultative intracellular coccobacilli of the genus Brucella . Interleukin-27 (IL-27) is a pleiotropic cytokine that serves a critical role in the development of immunity against Brucella . IL-27 single nucleotide polymorphisms (SNPs) may influence susceptibility to brucellosis by altering the expression and/or function of this cytokine. This study sought to examine the potential association between IL-27 genetic polymorphisms and brucellosis susceptibility among Iranian individuals. Methods: The study comprised 207 patients diagnosed with brucellosis and 82 healthy livestock workers as controls matched geographically to the patients’ population. IL-27 SNPs at positions −964 A/G, 2905 T/G, and 4730 T/C were genotyped and then evaluated through case–control comparisons. Results: Genotype analysis revealed a significantly higher frequency of the TG genotype at rs17855750 in controls compared to patients ( p = 0.0002). Conversely, the TT genotype at rs17855750 and the CC genotype at rs181206 were more frequent in patients ( p = 0.012 and p = 0.026, respectively). Furthermore, specific haplotypes (AGT and GGT) and haplogenotypes (ATT/AGT, GTC/GGT, and ATT/GTT) showed a significantly different distribution between the groups, being more prevalent in controls. Conclusion: This study provides evidence for an association between IL-27 gene variants and brucellosis susceptibility, reinforcing the role of host genetics in Brucella infection. These findings not only enhance our understanding of brucellosis pathogenesis but also pave the way for genetic-based risk assessment and the development of novel therapeutic strategies.

  • Open Access

    CircRNAs and lncRNAs in Allergic Rhinitis: Mechanisms and Therapeutic Insights

    by Elham Mohammadisoleimani, Abbas Shahi, Ghaidaa Raheem Lateef Al-Awsi, Zahra Firoozi, Farshad Dehghani, Hosein Mansoori, Ali Moravej, Yaser Mansoori

    Allergic rhinitis (AR) is a nasal inflammatory disease that affects people all across the world and has a high prevalence rate, with estimates suggesting it affects up to 20%–40% of the population. Its underlying processes regarding the control of the innate immune response remain unknown. Understanding the underlying immunological systems is the key to creating more effective and precise therapies. Both long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) have complex functional processes. Briefly, lncRNAs are found in the nucleus and the cytoplasm. They may interact with chromatin complexes, regulatory proteins, and enzyme cofactors, bind DNA/RNA‐binding proteins (RBPs), and can also act as sponges of microRNAs (miRNAs). A new family of endogenous ncRNA is called circRNAs that are stable and conserved. Unlike linear RNA, circRNA is a kind of single‐stranded RNA that forms a covalently closed continuous loop. CircRNAs have a crucial function in the regulation of inflammatory disorders. This review focuses primarily on new investigations of the function, regulatory mechanism, and therapeutic potential of ncRNAs, particularly lncRNA and circRNA, in AR.

  • AI-Driven Biomarker Discovery and Personalized Allergy Treatment: Utilizing Machine Learning and NGS

    by Mahbod Fazlali, Maedeh Nasira, Ali Moravej

    PURPOSE OF REVIEW: This review explores the transformative potential of artificial intelligence (AI) and next-generation sequencing (NGS) in allergy diagnostics and treatment. It focuses on leveraging these technologies to enhance precision in biomarker discovery, patient stratification, and personalized management strategies for allergic diseases. RECENT FINDINGS: AI-driven algorithms, particularly machine learning and deep learning, have enabled the identification of complex molecular patterns and predictive markers in allergies, such as IgE levels and cytokine profiles. Integration with NGS techniques, including single-cell RNA sequencing, has uncovered unique immune response signatures, providing insights into molecular mechanisms driving allergic reactions. These innovations have advanced diagnostic accuracy, treatment personalization, and real-time monitoring capabilities, especially in allergen immunotherapy. Combining AI and NGS technologies represents a paradigm shift in allergy research and clinical practice. These advancements facilitate precision diagnostics and personalized treatments, ensuring safer and more effective interventions tailored to individual patient profiles. Despite data integration and clinical implementation challenges, these technologies promise improved outcomes and quality of life for allergy sufferers.


  • Comparing the distribution of common human papillomavirus genotypes among the population of Fars province in southwest Iran with the genotypes included in the available HPV vaccines

    by Mahtab Kalani, Fatemeh Mirzaei, Haniyeh Keyghobadi, Gholamhossein Keighobadi, Atefeh Raoofat, Mehdi Kalani, Ali Moravej

    Background Given the strong association between high-risk HPV genotypes, such as HPV 16 and 18, and cervical cancer, this study aimed to compare the distribution of common HPV genotypes in the southwest Iranian population with those included in the available vaccines. Methods Based on the sample quality, DNA was extracted from the biological samples of 8036 individuals included in the study using three different methods (automated instrument, column, and precipitation), and a total of 21 different HPV genotypes were detected using real-time PCR. Results The majority of participants were women (> 99%), with a positive rate of HPV infection of 29.9%, in which high-risk genotypes were dominant in 84.9% cases. The highest rate of HPV infections was observed in the age ≤ 30 years (35.9%). HPV 6 and 16 were the most frequent low- and high-risk genotypes, respectively. Multi HPV infections were observed in 35% of positive samples and the highest cross infections were observed between HPV6 and 16. Co-infection with HPV 16 and 18 was observed in 21 positive samples (1%). Although vaccination is essential to reduce the outcome of HPV infections, such as cervical cancer, other frequently occurring high-risk genotypes are not included in the 9-valent vaccine. Conclusion Since the association between cervical cancer and other high-risk HPV types rather than 16 and 18 has been less studied, investigating their pathogenicity in cervical cancer is recommended. Furthermore, the new generation of HPV vaccines should contain other frequently occurring high-risk genotypes beyond those currently covered in approved vaccines.


  • Treatment effects on IL‐9+CD4+ T cells and the cytokines influencing IL‐9 production in paediatric visceral leishmaniasis

    by Ali Moravej, Maral Choopanizadeh, Bahman Pourabbas, Gholamreza Pouladfar, Mehdi Kalani

    Aims: Given the involvement of IL‐9 in the immune responses to parasitic infections, we aimed to determine alterations in the levels of IL‐9+CD4+ T cells and the cytokines influencing their differentiations and functions following treatment in paediatric visceral leishmaniasis (VL).Methods and results: Eighteen VL and 20 healthy children were included. The levels of IL‐9+CD4+ T cells and cytokines influencing their differentiations and functions were measured in the blood and PBMC culture supernatant at the onset of diagnosis and 1 and 2 weeks and 2 months after treatment, using flow cytometer. IL‐9+CD4+ T cells, IL‐2 and TNF‐α were significantly higher in the blood of VL patients than those in the controls; however, following treatment, IL‐9+CD4+ T cells down‐regulated and IL‐33 and IFN‐γ significantly up‐regulated. After ex vivo stimulation, although the released cytokines were not significantly different between the study groups, the levels of IL‐2, IL‐9 and IFN‐γ significantly decreased.Conclusions: The higher frequency of IL‐9+CD4+ T cells and its decline following treatment implies their roles in the immunopathogenesis of VL; however, at the diagnosis onset, lower levels of serum IL‐9 and its higher level in the culture supernatant may confer in vivo dysfunction of IL‐9+CD4+ T cells in the acute phase of human VL.


  • Open Access

    The Effect of Mesenchymal Stem Cells on the Expression of IDOand Qa2 Molecules in Dendritic Cells

    by Ali Moravej, Amin Kouhpayeh, Bita Geramizadeh, Negar Azarpira, Ramin Yaghobi, Yaser Mansoori, Mohammad-Hossein Karimi

    Purpose: Mesenchymal stem cells (MSCs) have been shown to reduce the activity of immunecells, including dendritic cells (DCs). But the exact mechanism of mesenchymal inhibitionof DCs is still unknown. In this study, the effect of mesenchymal cells on the expression ofindoleamine dioxygenase (IDO) and Qa2 molecules in DCs was evaluated.Methods: MSCs and DCs were respectively isolated from the bone marrow and spleen of BALB/cmice. Then DCs were co-cultured with MSCs in the present and absence of lipopolysaccharides(LPS). Then the expression of mRNA and protein of IDO and Qa2 molecules were investigatedin DCs that were treated with MSCs.Results: The expression of IDO and Qa2 mRNA in DCs that were treated with MSCs did notsignificantly differ from the control group. The expression of IDO protein in DCs that were coculturedwith MSCs (in 1:10 and 1:50 ratios) in absence of LPS was increased, although theywere not statistically significant (P values: 0.24 and 0.18, respectively). The expression of Qa2protein in DCs that were co-cultured with MSCs (in 1:10 and 1:50 ratios) in presence of LPS wasincreased, although they were not statistically significant (P-values: 0.09 and 0.33, respectively).Conclusion: Our results denied the possibility that MSCs led to the induction of tolerogenic DCsby increasing the expression of the IDO and Qa2 immunomodulatory molecules.


  • Open Access

    Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population

    by Zhaleh Farokhizadeh, Sahar Dehbidi, Bita Geramizadeh, Ramin Yaghobi, Seyed Ali Malekhosseini, Mehrdad Behmanesh, Mohammad Hossein Sanati, Afsoon Afshari, Ali Moravej, Mohammad Hossein Karimi

    Farokhizadeh Z, et al. Ann Lab Med. 2019 Jan;39(1):58-66. https://doi.org/10.3343/alm.2019.39.1.58


  • Evaluation of Immunomodulatory Effects of Mesenchymal Stem Cells Soluble Factors on miR-155 and miR-23b Expression in Mice Dendritic Cells

    by Aida Karachi, Mehdi Fazeli, Mohammad Hossein Karimi, Bita Geramizadeh, Ali Moravej, Salimeh Ebrahimnezhad, Afsoon Afshari

    (2015). Evaluation of Immunomodulatory Effects of Mesenchymal Stem Cells Soluble Factors on miR-155 and miR-23b Expression in Mice Dendritic Cells. Immunological Investigations: Vol. 44, No. 5, pp. 427-437.


  • Immunostimulatory Effects of Leishmania Infantum HSP70 Recombinant Protein on Dendritic Cells in Vitro and in Vivo

    by Manoochehr Rasouli, Mohammad Hossein Karimi, Mehdi Kalani, Salimeh Ebrahimnezhad, Manadana Namayandeh, Ali Moravej

    Activation of dendritic cells (DCs) has an important role in immunity against Leishmania. We investigated the effect of Leishmania infantum (L. infantum) heat shock protein 70 recombinant protein (rHSP70) as a vaccine on DC maturation and function. BALB/c mouse splenic DCs were isolated and treated with different concentrations of rHSP70. Maturation markers, cytokine production and capability of DCs to proliferate allogeneic T cells were evaluated. Furthermore, this recombinant protein was injected into BALB/c mice, and expression of CD86, CD40 and MHC class II molecules by their splenic DCs were evaluated. rHSP70 significantly increases the production of IL-12p70 by DCs. It had no effect on allogeneic T-cell proliferation in mixed lymphocyte reaction. It increased IFN-γ and decreased IL-4 cytokine level in mixed lymphocyte reaction supernatant. The in vitro study showed that rHSP70 had no significant effect neither on the percentage of CD40(+), CD86(+) and MHC class II(+) DCs nor on the mean fluorescent intensity. However, in vivo results showed that rHSP70 increases the percentage of CD86-, CD40- and MHC class II-expressing cells as well as mean fluorescent intensity of CD40 and MHC class II. This study demonstrated the capability of L. infantum-derived rHSP70 in maturating BALB/c mice splenic DCs and in vivo polarization of immunity to a Th1 response.


    • 1 September 2013
      • Vol. 10  (3) , 158-66

    Interleukin-8 but not interleukin-6 variant may affect susceptibility to brucellosis.

    by Sadaf Asaei, Manoochehr Rasouli, Ali Moravej

    Increased levels of interleukin-8 (IL-8) and interleukin-6 (IL-6) in acute human brucellosis have been reported. Previous studies have shown that the production and level of IL-6 and IL-8 cytokines are associated with the polymorphism of the encoding genes. To investigate the probable association between IL-6 (-174 C/G) and IL-8 (-251 A/T) gene polymorphisms and susceptibility/resistance to brucellosis. The patient group included 196 patients suffering from Brucella infection and the control group consisted of 82 healthy animal husbandmen from the same geographical area. IL-8 (-251 A/C) and IL-6 (-174 C/G) gene polymorphisms were analyzed by PCR-RFLP and Allele Specific PCR (AS-PCR) respectively. The frequency of -251 IL-8 AA genotype was significantly lower in the controls compared with that of the patients (p=0.0051), while the frequencies of other genotypes (AT and TT) and alleles (A and T) were not significantly different among the participants. No association was found between IL-6 (-174 C/G) polymorphism and brucellosis. This study indicates that the IL-8 -251 AA genotype may be considered as a genetic susceptibility factor for brucellosis.